Advancing N = 1 therapies: Building ecosystems for personalized genetic medicine

Key Points

• N=1 therapies enhance patient care through tailored treatments, offering specific genetic insights, and personalized strategies for individuals.
• This approach analyzes individual genetic data and aligns it with healthcare interventions to improve treatment effectiveness and outcomes.
• Ecosystem development involves collaboration among stakeholders to create personalized medicine frameworks and leverage genetic information.
• Support for N=1 therapies may enable broader implementation of personalized strategies in clinical settings, improving health management.